CoChat

Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?

Corbould, A. · 2008 · Diabetes/Metabolism Research and Reviews
Cited by 144

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Hyperinsulinemia as a consequence of insulin resistance causes hyperandrogenemia in women. The objective was to review evidence for the converse situation, i.e. whether androgens adversely influence insulin action. Androgen excess could potentially contribute to the pathogenesis of insulin resistance in women with polycystic ovary syndrome (PCOS), metabolic syndrome/type 2 diabetes, and in obese peripubertal girls. An Entrez‐PubMed search was conducted to identify studies addressing the relationship of androgens with metabolic syndrome/type 2 diabetes in women. Studies reporting outcomes of androgen administration, interventions to reduce androgen effects in hyperandrogenemic women, and basic studies investigating androgen effects on insulin target tissues were reviewed. Multiple studies showed associations between serum testosterone and insulin resistance or metabolic syndrome/type 2 diabetes risk in women, but their cross‐sectional nature did not allow conclusions about causality. Androgen administration to healthy women was associated with development of insulin resistance. Intervention studies in women with hyperandrogenism were limited by small subject numbers and use of indirect methods for assessing insulin sensitivity. However, in three of the seven studies using euglycemic hyperinsulinemic clamps, reduction of androgen levels or blockade of androgen action improved insulin sensitivity. Testosterone administration to female rats caused skeletal muscle insulin resistance. Testosterone induced insulin resistance in adipocytes of women in vitro. In conclusion, the metabolic consequences of androgen excess in women have been under‐researched. Studies of long‐term interventions that lower androgen levels or block androgen effects in young women with hyperandrogenism are needed to determine whether these might protect against metabolic syndrome/type 2 diabetes in later life. Copyright © 2008 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/dmrr.872

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 110

  1. 10.1038/nature05485 · DOI · Paper page
  2. 10.1210/edrv-12-1-3 · DOI · Paper page
  3. 10.1210/er.18.6.774 · DOI · Paper page
  4. 10.1016/j.mehy.2005.09.057 · DOI
  5. 10.1111/j.1365-2796.1993.tb01016.x · DOI
  6. 10.1210/jc.2005-2665 · DOI
  7. 10.1042/cs1020151 · DOI · Paper page
  8. 10.1016/j.biochi.2004.11.012 · DOI
  9. 10.1001/jama.295.11.1288 · DOI · Paper page
  10. 10.1016/0960-0760(91)90310-2 · DOI · Paper page
  11. 10.1210/jc.2006-1990 · DOI · Paper page
  12. 10.1093/aje/154.6.489 · DOI · Paper page
  13. 10.1210/jcem.84.6.5824 · doi:10.1210/jcem.84.6.5824 · Paper page
  14. 10.1093/aje/155.5.437 · DOI · Paper page
  15. 10.1530/EJE-06-0702 · DOI
  16. 10.1042/cs0800199 · DOI · Paper page
  17. 10.1053/meta.2002.29997 · DOI · Paper page
  18. 10.1152/ajpendo.00339.2006 · DOI · Paper page
  19. 10.1093/aje/kwh250 · DOI · Paper page
  20. 10.1161/01.CIR.0000157697.54255.CE · DOI · Paper page
  21. 10.1210/jc.2006-1895 · DOI · Paper page
  22. 10.2337/diacare.19.12.1399 · DOI · Paper page
  23. 10.2337/diacare.23.7.912 · DOI · Paper page
  24. 10.2337/diacare.23.1.74 · DOI
  25. 10.1016/j.metabol.2005.06.011 · DOI
  26. 10.1210/jc.77.1.56 · DOI · Paper page
  27. 10.1016/S0015-0282(03)00347-9 · DOI
  28. 10.1210/jc.2005-1852 · DOI · Paper page
  29. 10.1210/jc.2006-2002 · DOI · Paper page
  30. 10.1210/jc.2007-0195 · DOI · Paper page
  31. Landon J, 1963, The effect of anabolic steroids on blood sugar and plasma insulin levels in man, Metabolism, 12, 924
  32. 10.1210/jc.79.1.265 · DOI · Paper page
  33. 10.1210/jc.83.12.4420 · DOI
  34. 10.1210/jc.81.6.2198 · DOI · Paper page
  35. 10.1097/00042192-200011000-00005 · DOI · Paper page
  36. 10.1016/j.fertnstert.2005.12.039 · DOI
  37. 10.1016/j.jsbmb.2004.02.003 · DOI
  38. 10.1002/14651858.CD006133.pub2 · DOI
  39. Shamma FN, 1995, The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions, Fertil Steril, 63, 767, 10.1016/S0015-0282(16)57479-2 · DOI
  40. 10.2337/dc06-2227 · DOI
  41. 10.1210/jc.83.6.2001 · DOI · Paper page
  42. 10.1210/jc.79.4.1158 · DOI · Paper page
  43. 10.1016/S0889-8545(05)70185-6 · DOI
  44. 10.1093/humrep/deh098 · DOI · Paper page
  45. 10.1210/jc.2004-2279 · DOI · Paper page
  46. 10.1210/jc.2006-1327 · DOI · Paper page
  47. 10.2337/diabetes.55.03.06.db05-0453 · DOI · Paper page
  48. 10.2337/diab.41.10.1257 · DOI · Paper page
  49. 10.1016/0026-0495(94)90013-2 · DOI
  50. 10.1016/j.metabol.2006.12.021 · DOI
  51. 10.1210/jcem-50-1-113 · DOI · Paper page
  52. 10.1210/jc.2005-1666 · DOI · Paper page
  53. 10.1210/jc.2004-1045 · DOI · Paper page
  54. 10.1210/jc.75.6.1421 · doi:10.1210/jc.75.6.1421 · Paper page
  55. 10.1159/000086363 · DOI · Paper page
  56. 10.1210/jcem-70-3-699 · DOI · Paper page
  57. 10.1016/0026-0495(95)90062-4 · DOI
  58. 10.1530/eje.0.1330718 · DOI · Paper page
  59. 10.1210/jc.81.3.952 · DOI · Paper page
  60. 10.1210/jcem.83.8.5041 · DOI · Paper page
  61. 10.1159/000070180 · DOI
  62. 10.1016/S0015-0282(16)56213-X · DOI
  63. 10.1093/humrep/14.4.893 · DOI
  64. 10.1016/S0015-0282(16)47716-2 · DOI
  65. 10.1016/S0015-0282(16)49211-3 · DOI · Paper page
  66. Lanzone A, 1990, Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist, Hum Reprod, 5, 143, 10.1093/oxfordjournals.humrep.a137058 · DOI · Paper page
  67. 10.1111/j.1365-2265.1990.tb00921.x · DOI
  68. Dale PO, 1992, Persistence of hyperinsulinemia in polycystic ovary syndrome after ovarian suppression by gonadotrophin‐releasing hormone agonist, Acta Endocrinol (Copenh), 126, 132
  69. 10.1007/BF03346907 · DOI
  70. 10.1016/S0015-0282(99)00275-7 · DOI
  71. 10.1080/09513590400004736 · DOI · Paper page
  72. 10.1159/000077827 · DOI
  73. 10.1007/BF03345529 · DOI
  74. 10.1210/jc.85.9.3251 · DOI · Paper page
  75. 10.1210/jc.87.6.2870 · DOI · Paper page
  76. 10.1016/S0015-0282(98)00006-5 · DOI
  77. 10.1210/jc.84.11.4278 · DOI
  78. 10.1111/j.1365-2265.1993.tb01771.x · DOI
  79. 10.1093/humrep/del466 · DOI · Paper page
  80. 10.1210/jc.87.2.716 · DOI
  81. 10.1016/S0079-6107(98)00056-X · DOI · Paper page
  82. 10.2337/diab.30.12.1000 · DOI · Paper page
  83. 10.1038/35055575 · DOI · Paper page
  84. 10.1152/ajpendo.00116.2005 · DOI · Paper page
  85. 10.1016/0022-4731(79)90514-4 · DOI
  86. 10.1111/j.1749-6632.1990.tb34293.x · DOI · Paper page
  87. 10.1172/JCI105588 · DOI · Paper page
  88. 10.1210/jcem-33-2-199 · DOI · Paper page
  89. 10.1016/0022-4731(83)90225-X · DOI
  90. 10.1210/jcem-59-5-949 · DOI · Paper page
  91. 10.1038/sj.ijo.0801886 · DOI
  92. 10.1210/jc.2003-030535 · DOI · Paper page
  93. 10.1677/joe.1.05762 · DOI · Paper page
  94. 10.1677/jme.1.01503 · DOI · Paper page
  95. 10.1046/j.1365-2362.1996.380603.x · DOI · Paper page
  96. Dieudonné MN, 1998, Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids, Am J Physiol, 274, C1645, 10.1152/ajpcell.1998.274.6.C1645 · DOI · Paper page
  97. 10.1055/s-2002-32144 · DOI · Paper page
  98. Dieudonne MN, 2000, Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site‐related specificities and possible involvement of insulin‐like growth factor 1 receptor and peroxisome proliferator‐activated receptor γ2, Endocrinol, 141, 649, 10.1210/endo.141.2.7293 · DOI · Paper page
  99. 10.1007/s00125-003-1324-0 · DOI · Paper page
  100. 10.1046/j.1463-1326.2002.00214.x · DOI · Paper page
  101. 10.1210/en.2006-0879 · DOI · Paper page
  102. Reiling BA, 1997, Effects of prenatal androgenization and lactation on adipose metabolism in finishing single‐calf heifers, J Anim Sci, 75, 1504, 10.2527/1997.7561504x · DOI
  103. 10.1016/j.lfs.2007.02.013 · DOI
  104. 10.1152/ajpendo.1990.259.4.E555 · DOI · Paper page
  105. Holmäng A, 1992, Effects of short‐term testosterone exposure on insulin sensitivity of muscles in female rats, Am J Physiol Endocrinol Metab, 262, E851, 10.1152/ajpendo.1992.262.6.E851 · DOI · Paper page
  106. 10.1046/j.1365-201X.2001.00801.x · DOI · Paper page
  107. Rincon J, 1996, Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment, Diabetes, 45, 615, 10.2337/diab.45.5.615 · DOI · Paper page
  108. 10.1074/jbc.M507339200 · DOI · Paper page
  109. 10.1210/en.2002-221123 · DOI · Paper page
  110. 10.1152/ajpendo.2001.281.4.E803 · DOI · Paper page

Cited by

Metadata

Authors
Corbould, A.
Venue
Diabetes/Metabolism Research and Reviews
Publisher
Wiley
Published
2008-07-10
Volume
24
Issue
7
Pages
520-532
ISSN
  • 1520-7552 (ISSN-L)
  • 1520-7560
OpenAlex
W1984659394
Cited by
144
References
41
FWCI
6.11
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.